Thin melanomas with unusual aggressive behavior: A report of nine cases

Journal of the American Academy of Dermatology

Volumn 34, Issue 3, 1996, Pages 439-444

  Vilmer, Catherine ^a   Bailly, C ^b   Le Doussal, V ^a   Lasry, S ^a   Guerin, P ^a   Delaunay, M M ^c   Mandard, A M ^d  

^a CENTRE RENÉ HUGUENIN   (France)

^b CENTRE LÉON BÉRARD   (France)

^c INSTITUT BERGONIÉ   (France)

^d CENTRE FRANÇOIS BACLESSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SIZE; CLINICAL TRIAL; FEMALE; HEAD AND NECK CANCER; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; SKIN CANCER; SUN EXPOSURE;

EID: 0029863732     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90436-3     Document Type: Article

References (40)

1. Clark WH, From L, Bernardino EA, et al. The histogenesis and biologic behaviour of primary human malignant melanomas of the skin. Cancer Res 1969;29:705-26.
2. Cascinelli N, Morabito A, Bufalino R, et al. Prognosis of stage I melanoma of the skin: World Health Organization collaborating centres for evaluation of methods of diagnosis and treatment of melanoma. Int J Cancer 1980;26:733-9.
3. Cascinelli N, Marubini E, Morabito A, et al. Prognostic factors for stage I malignant melanoma of the skin: a review. Stat Med 1985;4:265-78.
4. Balch CM, Murad TM, Soong S-J, et al. A multifactorial analysis of melanoma: prognostic histopathological factors comparing Clark's and Breslow's staging methods. Ann Surg 1978;188:732-42.
5. Breslow A. Prognostic factors in the treatment of cutaneous melanoma. J Cutan Pathol 1979;6:208-12.
6. Day CL, Mihm MC, Lew RA, et al. Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51-3.99 mm): a conceptual model for tumor growth and metastasis. Ann Surg 1982;195:35-43.
7. Morton DL, Davtyan DG, Wanek LA, et al. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness. Cancer 1993;71:3737-43.
8. Breslow A, Macht SD. Evaluation of prognosis in stage I cutaneous melanoma. Plast Reconstr Surg 1978;61:342-6.
9. Balch CM, Soong S-J, Shaw HM, et al. An analysis of prognostic factors in 4000 patients with cutaneous melanoma. In: Balch CM, Milton GW, Shaw HM, et al, eds. Cutaneous melanoma: clinical management and treatment. Philadelphia: JB Lippincott, 1985:321-52.
10. Trau H, Rigel DS, Harris MN, et al. Metastases of thin melanomas. Cancer 1983;51:553-6.
11. Kelly JW, Sagebiel RW, Clyman S, et al. Thin level IV malignant melanoma: a subset in which level is the major prognostic indicator. Ann Surg 1985;202:98-103.
12. Naruns PL, Nizze JA, Cochran AJ, et al. Recurrence potential of thin primary melanomas. Cancer 1986;57:545-8.
13. Ronan SG, Eng AM, Briere HA, et al. Thin malignant melanomas with regression and metastases. Arch Dermatol 1987;123:1326-30.
14. Shaw HM, McCarthy WH, McCarthy SW, et al. Thin malignant melanomas and recurrence potential. Arch Surg 1987;122:1147-50.
15. Slingluff CL, Vollmer RT, Reintgen DS, et al. Lethal "thin" malignant melanoma: identifying patients at risk. Ann Surg 1988;208:150-61.
16. Shaw HM, Rivers JK, McCarthy SW, et al. Cutaneous melanomas exhibiting unusual biologic behavior. World J Surg 1992;16:196-202.
17. Pontikes LA, Temple WJ, Cassar SL, et al. Influence of level and depth on recurrence rate in thin melanomas. Am J Surg 1993;165:225-8.
18. Slingluff CL, Dodge RK, Stanley WE, et al. The annual risk of melanoma progression: implications for the concept of cure. Cancer 1992;70:1917-27.
19. McGovern VJ. The classification of melanoma and its relationship with prognosis. Pathology 1970;2:85-98.
20. McGovern VJ. Spontaneous regression of melanoma. Pathology 1975;7:91-9.
21. Ackerman AB, Su WPD. The histology of cutaneous malignant melanoma. In: Kopf AW, Bart RS, Rodriguez-Sains R, et al, eds. Malignant melanoma. New York: Masson Publishing USA, 1977:62-8.
22. Woods JE, Soule EH, Creagan ET. Metastasis and death in patients with thin melanomas (less than 0.76 mm). Ann Surg 1983;198:63-4.
23. Kuehnl-Petzoldt C, Keil H, Schoepf E. Prognostic significance of the patient's sex, tumor site, and mitotic rate in thin (less than or equal to 1.5 mm) melanoma. Arch Dermatol Res 1984;276:151-5.
24. Urist MM, Balch CM, Soong S-J, et al. Head and neck melanoma in 534 clinical stage I patients: a prognostic factors analysis and results of surgical treatment. Ann Surg 1984;200:769-75.
25. Andersson AP, Gottlieb J, Drzewiecki KT, et al. Skin melanoma of the head and neck: prognostic factors and recurrence-free survival in 512 patients. Cancer 1992;69:1153-6.
26. O'Brien CJ, Coates AS, Petersen-Schaefer K, et al. Experience with 998 cutaneous melanoma of the head and neck over 30 years. Am J Surg 1991;162:310-4.
27. Ringborg U, Afzelius LE, Lagerlöf B, et al. Cutaneous malignant melanoma of the head and neck. Cancer 1993; 71:751-8.
28. Augustsson A, Stierner U, Rosdahl I, et al. Regional distribution of melanocytic naevi in relation to sun exposure, and site-specific counts predicting total number of naevi. Acta Dermat Venereol (Stockh) 1992;72:123-7.
29. Kripke ML. Speculations on the role of ultraviolet radiation in the development of malignant melanoma. J Natl Cancer Inst 1979;63:541-5.
30. Schwarz T, Urbanska A, Gschnait F, et al. Inhibition of the induction of contact hypersensibility by UV mediated epidermal cytokine. I. Invest Dermatol 1986;87:289-91.
31. Weiss J, Schwechheimer K, Cavenee WK, et al. Mutation and expression of the p53 gene in malignant melanoma cell lines. Int J Cancer 1993;54:693-9.
32. Kanjilal S, Pierceall WE, Anathaswamy HN. Ultraviolet radiation in the pathogenesis of skin cancers: involvement of ras and p53 genes. Cancer Bull 1993;45:205-11.
33. Miller HJ. Mutagenic specificity of ultraviolet light. J Mol Biol 1985;182:45-68.
34. Gromet MA, Epstein WL, Blois MS. The regressing thin malignant melanoma: a distinctive lesion with metastatic potential. Cancer 1978;42:2282-92.
35. Sondergaard K, Hou-Jensen K. Partial regression in thin primary cutaneous melanomas clinical stage I. Virchows Arch A Pathol Anat Histopathol 1985;408:241-7.
36. Wanebo HJ, Cooper PJ, Hagar RW. Thin (≤ 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression. Ann Surg 1985;201:499-504.
37. Shaw HM, McCarthy SW, McCarthy WH, et al. Thin regressing malignant melanoma: significance of concurrent regional lymph node metastases. Histopathology 1989;15: 257-65.
38. Morton DL, Davtyan DG, Wanek LA, et al. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness. Cancer 1993;71:3737-43.
39. Prade M, Sancho-Garnier H, Cesarini JP, et al. Difficulties encountered in the application of Clark classification and the Breslow thickness measurement in cutaneous malignant melanoma. Int J Cancer 1980;26:159-63.
40. Colloby PS, West KP, Fletcher A. Observer variation in the measurement of Breslow depth and Clark's level in thin cutaneous malignant melanoma. J Pathol 1991;163:245-50.